ClinConnect ClinConnect Logo
Search / Trial NCT05599750

Suture Repair vs Mesh Repair for Incisional Hernia

Launched by CLAYTON PETRO · Oct 26, 2022

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring two different methods for repairing incisional hernias, which are bulges that can occur through a scar in the abdominal wall. Researchers want to find out if using stitches alone (suture repair) is just as good as using a mesh material for the repair in terms of patients' quality of life one year after surgery. The trial focuses on patients with hernias that are between 2 and 6 centimeters wide and aims to determine if there are any significant differences in how patients feel after their procedure.

To participate in this trial, you need to be an adult over 18 years old, have an incisional hernia between 2 and 6 centimeters wide, and be in good general health (classified as CDC class I). However, people with certain conditions, such as those needing emergency surgery or those who have had previous hernia repairs with mesh at the same site, are not eligible. If you join, you can expect to be randomly assigned to either the stitch repair or mesh repair group and will be followed up a year later to see how you’re doing. This study is currently recruiting participants, and your involvement could help improve future hernia repair techniques.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults \>18 years old.
  • Anticipated hernia defect 2-6cm in width
  • Non-emergent case
  • CDC class I
  • Patients who previously underwent primary ventral hernia repair without the use of mesh
  • Incisional hernia
  • Exclusion Criteria:
  • Emergent cases
  • Patients \< 18 years old
  • Patients who are pregnant
  • Patients who previously underwent a prior ventral hernia repair with mesh at the site of the intended repair. Abdominal mesh in separate locations would be allowed.
  • Ventral hernia \<2cm or \> 6 cm in width
  • Primary hernia
  • CDC wound class II-IV

About Clayton Petro

Clayton Petro is a leading clinical trial sponsor dedicated to advancing medical research and innovation through the development of novel therapies. With a strong focus on improving patient outcomes, Clayton Petro collaborates with healthcare professionals, regulatory bodies, and research institutions to design and execute high-quality clinical trials across various therapeutic areas. Their commitment to ethical practices and rigorous scientific standards ensures the integrity of their research, while their experienced team of professionals works diligently to bring groundbreaking treatments to market, ultimately enhancing the quality of care for patients worldwide.

Locations

Nashville, Tennessee, United States

Gainesville, Florida, United States

Gainesville, Florida, United States

Columbus, Ohio, United States

Cleveland, Ohio, United States

Patients applied

0 patients applied

Trial Officials

Clayton Petro, MD

Principal Investigator

The Cleveland Clinic

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials